SIS
CHRS icon

Sound Income Strategies’s Coherus Oncology CHRS Stock Holding History

Sound Income Strategies’s Portfolio CHRS Stock Details CHRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-200
Closed -$348 – 812
2026
Q1 		$348 Hold
200
– – ﹤0.01% 2427
2025
Q4 		$320 Hold
200
– – ﹤0.01% 2415
2025
Q3 		$364 Hold
200
– – ﹤0.01% 1564
2025
Q2 		$146 Buy
+200
New +$173 ﹤0.01% 1534

Other funds holding CHRS

TGY2IT
Timothy G. Youngquist 2020 Irrevocable Trust Fort Myers, Florida $510M AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
CWG
C WorldWide Group Copenhagen, Denmark $4.15B AUM 13.14% 1-Year Est. Return
PAM
Panagora Asset Management Boston, Massachusetts $32.6B AUM 52.29% 1-Year Est. Return
SO
STRS Ohio Columbus, Ohio $26.7B AUM 43.32% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Sound Income Strategies's CHRS Position: Q2 2026 in Review

Sound Income Strategies sold out of Coherus Oncology (CHRS) in Q2 2026, closing a stake of 200 shares — an estimated $348 sold.

Sound Income Strategies first reported a position in CHRS in Q2 2025 and held it in 4 quarters. The position peaked at $364 in Q3 2025. 85 funds tracked by Wall St. Rank hold CHRS as of Q2 2026.

  • Sound Income Strategies reported no remaining Coherus Oncology position as of Q2 2026 after selling out during the quarter.
  • Sound Income Strategies sold 200 Coherus Oncology shares in Q2 2026, an estimated $348.
  • Sound Income Strategies first reported a position in Coherus Oncology in Q2 2025 and held it in 4 quarters.
  • Sound Income Strategies's Coherus Oncology position peaked at $364 in Q3 2025.
  • 85 funds tracked by Wall St. Rank held Coherus Oncology as of Q2 2026.

Based on Sound Income Strategies's 13F filing for Q2 2026, filed 20 Jul 2026.